or Try an Advanced Search...

    Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 0.99 0.45% 0.00
    VRCA closed up 0.45 percent on Friday, November 22, 2024, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical VRCA trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Pocket Pivot Bullish Swing Setup 0.45%
    Volume Surge Other 0.45%
    Wide Bands Range Expansion 0.45%
    1,2,3 Retracement Bearish Bearish Swing Setup 12.07%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 12.07%
    Older End-of-Day Signals for VRCA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Possible Inside Day 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Down 3% 1 day ago
    Up 3% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VRCA Chart by TradingView
    Basic chart:

    Profile

    Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts

    Is VRCA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 5 Verrica downgraded to sector perform by RBC Capital
    Nov 4 Verrica Pharmaceuticals Non-GAAP EPS of -$0.43 misses by $0.04
    Nov 4 Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition
    Oct 9 Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...
    Oct 3 Verrica downgraded to hold by Needham, cash position cited
    Oct 3 This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
    Oct 2 Verrica Pharmaceuticals reports restructuring of commercial organization
    Oct 2 Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
    Sep 29 Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
    Sep 25 Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?
    See more VRCA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4
    52 Week Low 0.7043
    Average Volume 900,992
    200-Day Moving Average 5.01
    50-Day Moving Average 1.35
    20-Day Moving Average 1.07
    10-Day Moving Average 0.91
    Average True Range 0.14
    RSI (14) 42.53
    ADX 28.7
    +DI 21.76
    -DI 25.87
    Chandelier Exit (Long, 3 ATRs) 1.31
    Chandelier Exit (Short, 3 ATRs) 1.13
    Upper Bollinger Bands 1.70
    Lower Bollinger Band 0.43
    Percent B (%b) 0.44
    BandWidth 118.71
    MACD Line -0.17
    MACD Signal Line -0.20
    MACD Histogram 0.0309
    Fundamentals Value
    Market Cap 41.83 Million
    Num Shares 42.1 Million
    EPS -1.08
    Price-to-Earnings (P/E) Ratio -0.92
    Price-to-Sales 72.34
    Price-to-Book 5.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.08
    Resistance 3 (R3) 1.08 1.05 1.07
    Resistance 2 (R2) 1.05 1.03 1.05 1.06
    Resistance 1 (R1) 1.02 1.01 1.04 1.02 1.06
    Pivot Point 0.99 0.99 1.00 0.99 0.99
    Support 1 (S1) 0.96 0.97 0.98 0.96 0.93
    Support 2 (S2) 0.93 0.95 0.93 0.92
    Support 3 (S3) 0.90 0.93 0.92
    Support 4 (S4) 0.90